Andreas Scorilas

17.6k citations
429 papers · 13.8k indexed · 1 hit paper · h-index 60
Topics
Coagulation, Bradykinin, Polyphosphates, and Angioedema (116 papers)Peptidase Inhibition and Analysis (66 papers)MicroRNA in disease regulation (59 papers)

In The Last Decade

Andreas Scorilas

421 papers receiving 13.6k citations

Hit Papers

Adverse effects of COVID-19 mRNA vaccines: the spike hypo...2022202620232024202250100150

Peers

Andreas Scorilas
Comparison fields: 5 of 159
  • Molecular Biology 7.3k
  • Cancer Research 3.9k
  • Genetics 3.8k
  • Oncology 3.6k
  • Hematology 1.7k
Replace Joel S. Greenberger with:
Joel S. Greenberger United States
Gary E. Gallick United States
Ninette Amariglio Israel
Ugo Testa Italy
Andrew L. Kung United States
Jacqueline Whang‐Peng Taiwan
Ruggero De Maria Italy
Ivan Bièche France
Kevin C. Gatter United Kingdom
Salvatore V. Pizzo United States
Andreas Scorilas relative to Joel S. Greenberger United States Joel S. Greenberger's profile →
Citations per field
00.5×1.5×2.3×
Joel S. Greenberger · 1×
Citations per year

Countries citing papers authored by Andreas Scorilas

Since Specialization
Citations

This map shows the geographic impact of Andreas Scorilas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Scorilas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Scorilas more than expected).

Fields of papers citing papers by Andreas Scorilas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Scorilas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Scorilas. The network helps show where Andreas Scorilas may publish in the future.

Co-authorship network of co-authors of Andreas Scorilas

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Scorilas. A scholar is included among the top collaborators of Andreas Scorilas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Scorilas. Andreas Scorilas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 2
4 3
5 1
6 2
7 2
8 20
9 4
10 0
11 8
12 96
13 31
14 16
15 173
16 64
17 86
18 59
19
Human kallikrein 5 (hK5): A hovel serum biomarker for ovarian and breast cancer.
3
20 29

About Andreas Scorilas

Andreas Scorilas is a scholar working on Genetics, Cancer Research and Hematology, having authored 429 papers that have together received 13.8k indexed citations. Recurring topics across this work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (116 papers), Peptidase Inhibition and Analysis (66 papers) and MicroRNA in disease regulation (59 papers). The work is most often cited by research in Genetics (3.8k citations), Cancer Research (3.9k citations) and Hematology (1.7k citations). Andreas Scorilas has collaborated with scholars based in Greece, Canada and United States. Frequent co-authors include Eleftherios P. Diamandis, Christos K. Kontos, George M. Yousef, Margaritis Avgeris, Maroulio Talieri, Hellinida Thomadaki, Konstantinos Mavridis, Panagiotis G. Adamopoulos, Alexandros Ardavanis and Iordanis N. Papadopoulos. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026